Author/Authors :
Talebi-Taher ، Mahshid نويسنده Department of Infectious Diseases, Rasoul-e-Akram General Teaching Hospital, , , Alavi Niakou ، Seyedeh -Nina نويسنده Department of Internal Medicine, Rasoul-e-Akram General Teaching Hospital , , Javad-Mousavi ، Seied Ali نويسنده Department of Pulmonary Medicine, Rasoul-e-Akram General Teaching Hospital, , , Vaziri ، Mohammad نويسنده Department of Thoracic Surgery, Rasoul-e-Akram General Teaching Hospital , , Iranpour، Aida نويسنده Department of Pulmonary Medicine , , Dehghani Mohammad Abadi، Maryam نويسنده Department of Transgenic Animal Science, Stem Cell Technology Research Center, Tehran, Iran ,
Abstract :
Pulmonary mucormycosis is a rare but fatal condition that frequently occurs in immunocompromised patients. Correct diagnosis and rapid start of preferred antifungal treatment need clinical suspicion. Patient’s symptoms may be confluent with other conditions such as bacterial and other fungal infections. We present a case of pulmonary mucormycosis in a patient with end stage renal disease successfully treated with a long course of amphotericin B deoxycholate (AmB) and upper lobectomy of the left lung despite of low pulmonary capacity.
